Početna stranicaMEHCQ • OTCMKTS
add
23andMe Holding Co
Preth. zaklj. cijena
4,24 $
Dnevni raspon
4,05 $ - 4,39 $
Godišnji raspon
0,47 $ - 10,81 $
Tržišna kapitalizacija
117,60 mil. USD
Prosječna količina
575,71 tis.
P/E omjer
-
Prinos dividende
-
Glavno tržište vrijednosnica
OTCMKTS
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
(USD) | ožu 2025.info | Godišnja promjena |
---|---|---|
Prihod | 45,15 mil. | −29,49 % |
Operativni troškovi | 65,51 mil. | −34,62 % |
Neto dohodak | −99,35 mil. | 52,43 % |
Neto profitabilnost | −220,04 | 32,54 % |
Zarada po dionici | — | — |
EBITDA | −45,06 mil. | 35,08 % |
Efektivna porezna stopa | 0,00 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
(USD) | ožu 2025.info | Godišnja promjena |
---|---|---|
Gotovinska i kratkoročna ulaganja | 38,25 mil. | −82,33 % |
Ukupna imovina | 159,89 mil. | −59,54 % |
Ukupne obveze | 186,64 mil. | −9,68 % |
Ukupni kapital | −26,74 mil. | — |
Dionice u optjecaju | 27,54 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | −4,37 | — |
Povrat imovine | −54,88 % | — |
Povrat kapitala | −230,70 % | — |
Tok novca
Neto promjena novca
(USD) | ožu 2025.info | Godišnja promjena |
---|---|---|
Neto dohodak | −99,35 mil. | 52,43 % |
Gotovina od poslovanja | −40,73 mil. | −57,97 % |
Gotovina iz ulaganja | −734,00 tis. | 65,80 % |
Gotovina iz financiranja | −529,00 tis. | −126,45 % |
Neto promjena novca | −41,99 mil. | −61,95 % |
Slobodan tok novca | −82,91 mil. | −285,64 % |
Više
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Osnovano
tra 2006
Web-lokacija
Zaposlenici
261